Search Login Register

Channelopathies Summary

Description: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.

Also Known As: Channelopathy

Networked: 710 relevant articles (15 outcomes, 42 trials/studies) for this Disease

Key Drugs and Agents for Channelopathies

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Sodium : 2 outcomes 8 studies in 127 results : IBA
  2. Potassium : 2 outcomes 3 studies in 65 results : IBA
  3. Mexiletine (Mexitil) : 2 outcomes 1 study in 2 results : FDA 5 Generic
  4. Anticonvulsants (Antiepileptic Drugs) : 2 outcomes in 3 results : IBA
  5. Ion Channels (Ion Channel) : 1 outcome 11 studies in 199 results : IBA
  6. Calcium : 1 outcome 4 studies in 75 results : IBA
  7. Sodium Channels (Sodium Channel) : 1 outcome 4 studies in 61 results : IBA
  8. Calcium Channels (Calcium Channel) : 1 outcome 3 studies in 31 results : IBA
  9. Nondystrophic myotonia : 1 outcome 1 study in 1 result : IBA
  10. Acetazolamide (Diamox) : 1 outcome in 4 results : FDA 13 Generic
Show All >>

Diseases Related to Channelopathies

  1. Epilepsy (Aura)
  2. Paralysis (Palsy)
  3. Myotonia
  4. Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)
  5. Ataxia (Dyssynergia)
Show All >>

Key Therapies for Channelopathies

Efficacy Chart >>
  1. Implantable Defibrillators (Implantable Cardioverter-Defibrillator) : 1 outcome 1 study in 15 results
  2. Tenotomy : 1 outcome in 1 result
  3. Thyroidectomy : 1 outcome in 1 result
  4. Denervation : 1 outcome in 1 result
  5. Drug Therapy (Chemotherapy) : 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.